BHCM
CBIO

Brevan Howard Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Brevan Howard Capital Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-233
Closed -$70K – 1126
2024
Q1 		$70K Buy
+233
New +$70K ﹤0.01% 873